Skip to content

ANGIODYNAMICS INC

ANGO · XNAS

CIK 1275187fmd_1KX8135ARZYE21DQE9PJ0VS2C8Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jun 01, 2009 to Aug 31, 2026, 66 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Total revenues270262271264291316339304292320
Cost of revenue126118115114134150165149135145
Gross profit144144156150157166174155158175
Research and development24242830363130322629
Selling, general and administrative106104112117117134144144145157
Total operating expenses155158165317192194225402198215
Operating income(11)(14)(9)(167)(35)(28)(51)(192)(40)(40)
Interest expense3351113(2)––
Interest and investment income––––––––––
Other non-operating income (expense)(3)(3)(0)(0)0(1)(1)(1)54
Income before taxes(14)(17)(15)(168)(36)(30)(54)(192)(34)(36)
Income tax expense(7)(11)(4)(1)(5)(3)(2)(7)(0)0
Net income from continuing operations(7)(6)(11)(167)(32)(27)(52)(184)(34)(37)
Net income51661(167)(32)(27)(52)(184)(34)(37)
ANGIODYNAMICS INC (ANGO) financial statements · FinancialMD